OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis
Olivia Sheppard, Michael P. Coleman
Exon Publications eBooks (2020), pp. 1-22
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Exosomes: Potential Disease Biomarkers and New Therapeutic Targets
María Isabel Mosquera Heredia, Luis Carlos Morales, Oscar M. Vidal, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1061-1061
Open Access | Times Cited: 100

Alzheimer’s disease: the role of extrinsic factors in its development, an investigation of the environmental enigma
Swathi Suresh, Ankul Singh S, Rapuru Rushendran, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 27

Akt signaling pathway: a potential therapy for Alzheimer’s disease through glycogen synthase kinase 3 beta inhibition
Joshua Limantoro, Bryan Gervais de Liyis, Jane Carissa Sutedja
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2023) Vol. 59, Iss. 1
Open Access | Times Cited: 23

Results and insights from a phase I clinical trial of Lomecel‐B for Alzheimer's disease
Mark Brody, Marc Agronin, Brad J. Herskowitz, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 1, pp. 261-273
Open Access | Times Cited: 36

Stem cell therapy for Alzheimer’s disease: An overview of experimental models and reality
Chuan Qin, Kewei Wang, Ling Zhang, et al.
Animal Models and Experimental Medicine (2022) Vol. 5, Iss. 1, pp. 15-26
Open Access | Times Cited: 31

Neuroprotective Effect of Chlorogenic Acid in an Animal Model of Sporadic Alzheimer's Disease Induced by Streptozotocin
Jéssica Rabelo Bezerra, Tyciane de Souza Nascimento, Juliete Tavares, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 7

Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer’s disease
Katarzyna Kucwaj‐Brysz, Hanna Baltrukevich, Kinga Czarnota, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 49, pp. 128275-128275
Open Access | Times Cited: 35

p-Coumaric acid mitigates passive avoidance memory and hippocampal synaptic plasticity impairments in aluminum chloride-induced Alzheimer's disease rat model
Masome Rashno, Parsa Gholipour, Iraj Salehi, et al.
Journal of Functional Foods (2022) Vol. 94, pp. 105117-105117
Open Access | Times Cited: 24

Circadian rhythm alterations affecting the pathology of neurodegenerative diseases
Jaquelini Betta Canever, Letícia Yoshitome Queiroz, Ericks Sousa Soares, et al.
Journal of Neurochemistry (2023) Vol. 168, Iss. 8, pp. 1475-1489
Open Access | Times Cited: 14

Transcranial magnetic stimulation treatment in Alzheimer’s disease: a meta-analysis of its efficacy as a function of protocol characteristics and degree of personalization
Arianna Menardi, Lisa Dotti, Ettore Ambrosini, et al.
Journal of Neurology (2022) Vol. 269, Iss. 10, pp. 5283-5301
Open Access | Times Cited: 22

Design, Synthesis, In Silico Studies and In Vitro Evaluation of New Indole- and/or Donepezil-like Hybrids as Multitarget-Directed Agents for Alzheimer’s Disease
Violina T. Angelova, B. Georgiev, Tania Pencheva, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1194-1194
Open Access | Times Cited: 13

Role of Human Serum Albumin in the Prevention and Treatment of Alzheimer’s Disease
Marina P. Shevelyova, Evgenia I. Deryusheva, Ekaterina L. Nemashkalova, et al.
Biology Bulletin Reviews (2024) Vol. 14, Iss. 1, pp. 29-42
Closed Access | Times Cited: 4

Serum clinical laboratory tests and risk of incident dementia: a prospective cohort study of 407,190 individuals
Xiao‐Yu He, Kevin H.M. Kuo, Yang Liu, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17

Enhanced in silico QSAR-based screening of butyrylcholinesterase inhibitors using multi-feature selection and machine learning
D. Sharmistha, M Prabha, Ravi Kiran, et al.
SAR and QSAR in environmental research (2025), pp. 1-21
Closed Access

Targeting amyloidogenic proteins through cyclic peptides – A medicinal chemistry perspective
Muhammad Kazim Zargaham, Ahsan Ibrahim, Madiha Ahmed, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 123, pp. 118165-118165
Closed Access

Assessment of Periodontal Health in Patients with Alzheimer's disease in Karachi, Pakistan
Ujala Mushtaque, Mujahid Khan, Rana Muhammad Sabir Tariq, et al.
Pakistan Journal of Health Sciences (2025), pp. 23-27
Closed Access

Role of Electrospun Conductive Polymeric Nanofibers for Inducing Neuronal Tissue Regeneration—A Novel Strategy for Targeting Neurodegenerative Disorders
Priya Palanisamy, Weslen Vedakumari Sathyaraj, Yovan Raja Pravin
Regenerative Engineering and Translational Medicine (2025)
Closed Access

Exploring Metformin’s Therapeutic Potential for Alzheimer’s Disease: An In-Silico Perspective Using Well-Tempered Funnel Metadynamics
Sunandini Swain, Atanu K. Metya
Journal of Chemical Information and Modeling (2025)
Closed Access

Role of Robotics in the Assessment of Neurodegenerative Disorders
Krishnasamy Tamilselvam Yokhesh
IntechOpen eBooks (2025)
Closed Access

Neuroglial Advances: New Roles for Established Players
Alexei Verkhratsky, Baoman Li, Jianqin Niu, et al.
Journal of Neurochemistry (2025) Vol. 169, Iss. 5
Closed Access

Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine
Sarkar Sardar Azeez, Rahin Shareef Hamad, Bahra Kakamin Hamad, et al.
Frontiers in Genome Editing (2024) Vol. 6
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top